GPR139 agonism may act as a preventive therapeutic avenue for regulating withdrawal syndrome and addiction symptoms through its ability to inhibit MORs via the activation of Gq/11 and the recruitment of β-arrestin to MORs. Here, GPR139 is linked to substance withdrawal syndrome.